ArticleFrontiers in cardiovascular medicine2026
Joint effects of arterial stiffness and polygenic risk on kidney function: the Dongfeng-Tongji cohort.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Arterial stiffness may contribute to decline in kidney function, but it is unknown whether the association of arterial stiffness with kidney function might be influenced by genetic risk. We aimed to investigate the association of arterial stiffness evaluated by brachial-ankle pulse wave velocity (baPWV) and polygenic score (PRS) with kidney function and the interaction between baPWV and PRS in middle-aged and older Chinese adults. Methods: We included 13,494 participants with an average age of 68 years from the Dongfeng-Tongji cohort in 2018. A PRS was calculated using 67 variants associated with estimated glomerular filtration rate (eGFR). Results: A total of 1,939 (14.4%) participants were defined as chronic kidney disease (CKD) (eGFR <60 mL/min/1.73 m Conclusions: BaPWV was associated with both reduced eGFR and elevated CKD risk, especially in the participants with high genetic risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.